 | Up a level |
Stalder, R; Brembilla, N; Conrad, C; Yawalkar, N; Navarini, A; Boehncke, W H; Kaya, G (2022). Interleukin-17E, inducible nitric oxide synthase and arginase1 as new biomarkers in the identification of neutrophilic dermatoses. Clinical and experimental dermatology, 47(4), pp. 675-683. Wiley 10.1111/ced.14988
Nast, A; Smith, C; Spuls, P I; Avila Valle, G; Bata-Csörgö, Z; Boonen, H; De Jong, E; Garcia-Doval, I; Gisondi, P; Kaur-Knudsen, D; Mahil, S; Mälkönen, T; Maul, J T; Mburu, S; Mrowietz, U; Reich, K; Remenyik, E; Rønholt, K M; Sator, P G; Schmitt-Egenolf, M; ... (2021). EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specific clinical and comorbid situations. Journal of the European Academy of Dermatology and Venereology : JEADV, 35(2), pp. 281-317. Wiley 10.1111/jdv.16926
Tang, M M; Spanou, Z; Tang, H; Schibler, F; Pelivani, N; Yawalkar, N (2012). Rapid downregulation of innate immune cells, interleukin-12 and interleukin-23 in generalized pustular psoriasis with infliximab in combination with acitretin. Dermatology, 225(4), pp. 338-43. Basel: Karger 10.1159/000346243
Mrowietz, U; Kragballe, K; Reich, K; Spuls, P; Griffiths, C E M; Nast, A; Franke, J; Antoniou, C; Arenberger, P; Balieva, F; Bylaite, M; Correia, O; Daudén, E; Gisondi, P; Iversen, L; Kemény, L; Lahfa, M; Nijsten, T; Rantanen, T; Reich, A; ... (2011). Definition of treatment goals for moderate to severe psoriasis: a European consensus. Archives of dermatological research, 303(1), pp. 1-10. Berlin: Springer 10.1007/s00403-010-1080-1
Schlapbach, C; Zawodniak, A; Irla, N; Adam, J; Hunger, R E; Yerly, D; Pichler, W J; Yawalkar, N (2011). NKp46+ cells express granulysin in multiple cutaneous adverse drug reactions. Allergy, 66(11), pp. 1469-76. Oxford: Wiley-Blackwell 10.1111/j.1398-9995.2011.02677.x
Bieler, G; Thorn, D; Huynh, C K; Tomicic, C; Steiner, U-C; Yawalkar, N; Danuser, B (2011). Acute life-threatening extrinsic allergic alveolitis in a paint controller. Occupational medicine, 61(6), pp. 440-2. Oxford: Oxford University Press 10.1093/occmed/kqr057
Irla, N; Schneiter, T; Haneke, E; Yawalkar, N (2010). Nail Lichen Planus: Successful Treatment with Etanercept. Case reports in dermatology, 2(3), pp. 173-176. Basel: Karger
Yawalkar, N (2010). Interview Ars Medici 9/2010: Viele Patienten werden unter Biologics weitgehend symptomfrei. Biologika bei Psoriasis. Hautsache, p. 5. Zürich: Schweizerische Psoriasis- und Vitiligo-Gesellschaft SPVG
Yawalkar, N (2009). Drug hypersensitivity. Acta clinica belgica, 64(6), pp. 529-33. Brussels: Acta clinica belgica
Michel, S; Yawalkar, N; Schnyder, B; Fischer, B; Helbling, A (2009). Eczematous skin reaction to atopy patch testing with cockroach in patients with atopic dermatitis. Journal of investigational allergology & clinical immunology, 19(3), pp. 173-9. Barcelona: Esmon Publicidad
Irla, N; Yawalkar, N (2009). Marked improvement in nail psoriasis during treatment with adalimumab. Dermatology, 219(4), pp. 353-6. Basel: Karger 10.1159/000252853
Mennicke, M; Zawodniak, A; Keller, M; Wilkens, L; Yawalkar, N; Stickel, F; Keogh, A; Inderbitzin, D; Candinas, D; Pichler, W J (2009). Fulminant liver failure after vancomycin in a sulfasalazine-induced DRESS syndrome: fatal recurrence after liver transplantation. American journal of transplantation, 9(9), pp. 2197-202. Oxford: Wiley-Blackwell 10.1111/j.1600-6143.2009.02788.x
Hunger, R E; Surovy, A M; Hassan, A S; Braathen, L R; Yawalkar, N (2008). Toll-like receptor 2 is highly expressed in lesions of acne inversa and colocalizes with C-type lectin receptor. British journal of dermatology, 158(4), pp. 691-7. Oxford: Wiley-Blackwell 10.1111/j.1365-2133.2007.08425.x
Hassan, AS; Kaelin, U; Braathen, LR; Yawalkar, N (2007). Clinical and immunopathologic findings during treatment of recalcitrant atopic eczema with efalizumab. Journal of the American Academy of Dermatology, 56(2), pp. 217-221. New York, N.Y.: Elsevier 10.1016/j.jaad.2006.08.025
Keller, B; Yawalkar, N; Pichler, C; Braathen, LR; Hunger, RE (2007). Hypersensitivity reaction against patent blue durign sentinel lymph node removal in three melanoma patients. American journal of surgery, -193(1), pp. 122-4. Amsterdam: Elsevier Science 10.1016/j.amjsurg.2006.03.013
Buettiker, U; Keller, M; Pichler, W J; Braathen, L R; Yawalkar, N (2006). Oral prednisolone induced acute generalized exanthematous pustulosis due to corticosteroids of group A confirmed by epicutaneous testing and lymphocyte transformation tests. Dermatology, 213(1), pp. 40-3. Basel: Karger 10.1159/000092837
Hunger, RE; Hassan, AS; Braathen, LR; Yawalkar, N (2006). Allergic contact dermatitis. Giornale italiano di dermatologia e venereologia(141), pp. 483-493. Torino: Edizioni Minerva Medica
Yawalkar, N; Hunger, R E; Buri, C; Schmid, S; Egli, F; Brand, C U; Mueller, C; Pichler, W J; Braathen, L R (2001). A comparative study of the expression of cytotoxic proteins in allergic contact dermatitis and psoriasis: spongiotic skin lesions in allergic contact dermatitis are highly infiltrated by T cells expressing perforin and granzyme B. American journal of pathology, 158(3), pp. 803-8. New York, N.Y.: Elsevier 10.1016/S0002-9440(10)64027-8
Yawalkar, N (2009). Management of psoriasis. In: Böcker W, Denk H (ed.) Pathologie. Basel: Karger
